Compare ETFs: LON:BTEC vs. IBB
LON:BTEC
IBB
Comparison
Average Return
In the past year, LON:BTEC returned a total of 39.18%, which is higher than IBB's 36.19% return. Over the past 5 years, LON:BTEC has had annualized average returns of 8.82%, compared to 7.42% for IBB. These numbers are adjusted for stock splits and assume dividends are reinvested.
Top 25 Holdings
| LON:BTEC - iShares NASDAQ US Biotechnology UCITS ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | GILD | Gilead Sciences, Inc. | 8.96% |
| 2 | AMGN | Amgen Inc. | 8.40% |
| 3 | VRTX | Vertex Pharmaceuticals Incorporated | 7.88% |
| 4 | MRNA | Moderna, Inc. | 6.52% |
| 5 | REGN | Regeneron Pharmaceuticals, Inc. | 5.88% |
| 6 | RVMD | Revolution Medicines, Inc. | 2.65% |
| 7 | BIIB | Biogen Inc. | 2.36% |
| 8 | ILMN | Illumina, Inc. | 2.07% |
| 9 | RPRX | Royalty Pharma plc | 1.93% |
| 10 | ROIV | Roivant Sciences Ltd. | 1.81% |
| 11 | ARGX | argenx SE | 1.62% |
| 12 | INSM | Insmed Incorporated | 1.61% |
| 13 | INCY | Incyte Corporation | 1.56% |
| 14 | UTHR | United Therapeutics Corporation | 1.55% |
| 15 | VTRS | Viatris Inc. | 1.47% |
| 16 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.34% |
| 17 | GH | Guardant Health, Inc. | 1.30% |
| 18 | MEDP | Medpace Holdings, Inc. | 1.17% |
| 19 | EXEL | Exelixis, Inc. | 1.11% |
| 20 | NBIX | Neurocrine Biosciences, Inc. | 1.08% |
| 21 | ASND | Ascendis Pharma A/S | 1.02% |
| 22 | JAZZ | Jazz Pharmaceuticals plc | 0.98% |
| 23 | BBIO | BridgeBio Pharma, Inc. | 0.96% |
| 24 | ONC | BeOne Medicines AG | 0.94% |
| 25 | TEM | Tempus AI, Inc. | 0.86% |
| View LON:BTEC holdings | |||
| IBB - iShares Biotechnology ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | GILD | Gilead Sciences, Inc. | 8.79% |
| 2 | AMGN | Amgen Inc. | 8.22% |
| 3 | VRTX | Vertex Pharmaceuticals Incorporated | 7.69% |
| 4 | MRNA | Moderna, Inc. | 6.61% |
| 5 | REGN | Regeneron Pharmaceuticals, Inc. | 6.13% |
| 6 | ARGX | argenx SE | 3.59% |
| 7 | NTRA | Natera, Inc. | 2.90% |
| 8 | RVMD | Revolution Medicines, Inc. | 2.59% |
| 9 | BIIB | Biogen Inc. | 2.51% |
| 10 | ONC | BeOne Medicines AG | 2.36% |
| 11 | ILMN | Illumina, Inc. | 2.24% |
| 12 | GMAB | Genmab A/S | 2.08% |
| 13 | INSM | Insmed Incorporated | 1.68% |
| 14 | INCY | Incyte Corporation | 1.65% |
| 15 | UTHR | United Therapeutics Corporation | 1.62% |
| 16 | ROIV | Roivant Sciences Ltd. | 1.43% |
| 17 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.40% |
| 18 | EXEL | Exelixis, Inc. | 1.16% |
| 19 | NBIX | Neurocrine Biosciences, Inc. | 1.14% |
| 20 | CRL | Charles River Laboratories International, Inc. | 1.12% |
| 21 | ASND | Ascendis Pharma A/S | 1.08% |
| 22 | MEDP | Medpace Holdings, Inc. | 1.02% |
| 23 | BBIO | BridgeBio Pharma, Inc. | 0.92% |
| 24 | HALO | Halozyme Therapeutics, Inc. | 0.78% |
| 25 | TECH | Bio-Techne Corporation | 0.76% |
| View IBB holdings | |||